Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Absci Corp (NQ: ABSI )

1.710 -0.020 (-1.16%)
Streaming Delayed Price Updated: 11:48 AM EDT, Mar 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Absci Corp

Absci to Participate in the B. Riley Securities' Life Sciences Tools Conference - Proteomics Setting the Blueprint for Innovative Drug Creation
From Absci Corporation
Via Globe NewsWire
Absci to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
From Absci Corporation
Via Globe NewsWire
Absci Expands in Europe with Launch of New Innovation Center and Additional Senior Leadership in Switzerland
The generative AI drug company ramps up its internal pipeline and R&D portfolio, tapping into European markets, talent, and tech 
From Absci Corporation
Via Globe NewsWire
Absci to Participate in the 43rd Annual Cowen Health Care Conference
From Absci Corporation
Via Globe NewsWire
St. John’s Cancer Institute Partners with Absci to Expedite Development of Cancer Therapies
From Absci Corporation
Via Globe NewsWire
Absci Deepens Scientific Advisory Board to Accelerate Generative AI Drug Creation
In silico antibody design expert Dr. Victor Greiff, synthetic biology pioneer Dr. Timothy Lu, and translational medicine veteran Dr. Hubert Truebel will strengthen Absci’s scientific leadership in... 
From Absci Corporation
Via Globe NewsWire
Absci First to Create and Validate De Novo Antibodies with Zero-Shot Generative AI
From Absci Corporation
Via Globe NewsWire
Absci to Participate in the 41st Annual J.P. Morgan Healthcare Conference
From Absci Corporation
Via Globe NewsWire
Absci to Participate in the 41st Annual J.P. Morgan Healthcare Conference
From Absci Corporation
Via Globe NewsWire
Absci to Participate in the Berenberg Discover AI Seminar
From Absci Corporation
Via Globe NewsWire
Absci to Participate in the Piper Sandler Healthcare Conference
From Absci Corporation
Via Globe NewsWire
Absci Reports Third Quarter 2022 Financial Results
From Absci Corporation
Via Globe NewsWire
Absci to Participate in the Stifel Healthcare Conference
From Absci Corporation
Via Globe NewsWire
Absci Welcomes Meta Senior Executive to Board of Directors
Technology veteran Dan Rabinovitsj provides expertise in collaborating with technology partners to catalyze innovation as Absci accelerates generative AI drug creation 
From Absci Corporation
Via Globe NewsWire
Absci to Participate in the 31st Annual Credit Suisse Healthcare Conference
From Absci Corporation
Via Globe NewsWire
Absci Appoints Veteran Pharma Executive Andreas Busch, PhD as Chief Innovation Officer
From Absci Corporation
Via Globe NewsWire
EQRx and Absci Announce Partnership to Discover and Develop Next-Generation Protein-Based Drugs
From EQRx and Absci
Via Business Wire
NASDAQ:ABSI Shareholder Notice: Investigation over Potential Securities Laws Violations by Absci Corporation
San Diego, CA -- (SBWIRE) -- 09/20/2021 -- Absci Corporation are under investigation concerning potential securities laws violations in connection with certain financial statements. 
Via SBWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.